(Q24241831)

https://api.crossref.org/works/10.1002%2F14651858.CD000119.PUB3

Prophylaxis of thrombotic and embolic events in acute ischemic stroke with the low-molecular-weight heparin certoparin: results of the PROTECT Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000119.PUB3

A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000119.PUB3

Randomized controlled study of heparin and low molecular weight heparin for prevention of deep-vein thrombosis in medical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000119.PUB3

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000119.PUB3

Low-molecular-weight heparins and heparinoids in acute ischemic stroke : a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000119.PUB3

Structure and activity of heparin and its fragments: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000119.PUB3

Anticoagulants for acute ischaemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000119.PUB3

Randomisation to protect against selection bias in healthcare trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000119.PUB3

Low molecular weight heparin in prevention of perioperative thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000119.PUB3

Prevention of venous thromboembolism after major orthopaedic surgery: is fondaparinux an advance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000119.PUB3

Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000119.PUB3

Antithrombotic therapy in acute ischaemic stroke: an overview of the completed randomised trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000119.PUB3

Anticoagulants for preventing recurrence following presumed non-cardioembolic ischaemic stroke or transient ischaemic attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000119.PUB3

Antiplatelet therapy for acute ischaemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000119.PUB3

Differences between low-molecular-weight and unfractionated heparin for venous thromboembolism prevention following ischemic stroke: a metaanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000119.PUB3

Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000119.PUB3

Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000119.PUB3

Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000119.PUB3

Heparin Study in Internal Medicine (HESIM): design and preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000119.PUB3

7 January 2021

The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000119.PUB3

7 January 2021

A multicentre, double-blind, randomized study to compare the safety and efficacy of once-daily ORG 10172 and twice-daily low-dose heparin in preventing deep-vein thrombosis in patients with acute ischaemic stroke

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000119.PUB3

7 January 2021

Treatment with anticoagulants in cerebral events (TRACE)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000119.PUB3

7 January 2021